It's for your glass skin
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for managing type 2 diabetes (under the brand name Ozempic) and chronic weight management (Wegovy)
However, long-term administration of GCs at high doses is frequently associated with severe adverse effects, in particular, metabolic disorders and atrophic effects, including musculoskeletal side effects (glucocorticoid-induced osteoporosis (GIO), osteonecrosis, myopathy), disorders of carbohydrate and fat metabolism (diabetes mellitus, dyslipidemia, obesity), gastrointestinal, cardiovascular effects (Fig
The strength of the anti-addictive effect of GLP-1s appears so clear that some physicians are already using these treatments off-label for patients with substance use disorders (SUD), despite ongoing shortages (particularly for Mounjaro / Zepbound) and complications with insurance coverage
Exploring the application of metal-based photothermal agents in photothermal therapy combined with immune checkpoint therapy
Traditionally, athletes dissolved baking soda into water and drank this solution
